Periodic Reporting for period 1 - DPP9-TACDrug (DPP9 degradation-induced pyroptosis for treatment of acute myeloid leukemia)

Acute myeloid leukemia (AML) is an aggressive malignancy of the blood and bone marrow, characterized by the rapid proliferation of abnormal myeloid cells. It is the most common type of acute leukemia in adults and remains challenging to treat due to its high relapse rate and...